Please Visit and Join the WeHeal LGL Leukemia Community
Information and References: Wikipedia | NIH
Patient Resources and Related Organizations: Leukemia and Lymphoma Society
News and Media: News-Medical.net
Clinical trials: Clinicaltrials.gov | In Clinical Trials | EU Clinical Trials Register | WeHeal Guide to Researching Clinical Trials
Large granular lymphocyte (LGL) leukemia is a rare cancer of a type of white blood cells called lymphocytes. LGL leukemia causes a slow increase in white blood cells called T lymphocytes, or T cells, which originate in the lymph system and bone marrow and help to fight infection. This disease usually affects people in their sixties. Symptoms include anemia; low levels of platelets (thrombocytopenia) and infection-fighting neutrophils (neutropenia) in the blood; and an enlarged spleen. About one-third of patients are asymptomatic at the time of diagnosis. The exact cause of LGL leukemia is unknown. Doctors can diagnose this disease through a bone marrow biopsy, or by using a specialized technique in which various types of blood or bone marrow cells are separated, identified, and counted.[1]
Please Visit and Join the WeHeal LGL Leukemia Community
WeHeal is very grateful to our valued sources of information which include Wikipedia, WebMD, ClinicalTrials.gov, Cancer.gov, Infoplease, and the US CDC (Center for Disease Control).